Search for: "Boehringer Ingelheim GmbH"
Results 41 - 51
of 51
Sort by Relevance
|
Sort by Date
6 Apr 2009, 8:20 am
., Boehringer Ingelheim GmbH, Genentech Inc., GlaxoSmithKline Plc and Novartis AG. [read post]
6 Feb 2009, 5:00 am
Stem cell research under Obama (Ars Technica) US: Oxford Gene Technology settles legal action with Bioarray Solutions over patents covering use of microassays for detection of DNA sequence variations (Patent Docs) US: BPAI affirms rejection of claims to an isolated protein over prior art disclosing nucleic acid encoding the protein: Ex parte Chuang (not precedential) (Patent Docs) (Post-Grant) US: Supreme petitioned to grant certiorari in two cases important to biotech patenting: In re Bilski and… [read post]
4 Feb 2009, 10:01 am
Of course, the skills of a well-trained patent attorney come in very handy in getting this kind of application over the high bar at the EPO.The latter approach is what at least one party took in the recent case of Laboratorios Almirall SA v Boehringer Ingelheim International GmbH [2009] EWHC 102 (Pat), the judgment of which was issued last week by His Honour Judge Fysh QC. [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel (Dasatinib)… [read post]
31 Dec 2008, 2:35 pm
Article 7(2) of Directive 89/104 ... is to be interpreted as meaning that it is for the parallel importer to furnish to the proprietor of the trade mark the information which is necessary and sufficient to enable the latter to determine whether the repackaging of the product under that trade mark is necessary in order to market it in the Member State of importation".The IPKat knows how pleased the Court of Appeal for England and Wales will be now that this ruling has been given, since that… [read post]
16 Aug 2008, 2:43 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
11 Jul 2008, 4:30 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
22 Feb 2008, 6:00 pm
: (GenericsWeb), EU: Pharmaceutical sector enquiry regarding possible misuse of IP rights: (GenericsWeb), India: Indian government seeks to be a leader in deep sea bed mining to provide competitive edge for pharmaceutical companies in the development of new drugs: (Spicy IP),India : Medical Devices Regulation Bill formulated: (Spicy IP),India : Pharma gets bigger - Novo Nordisk and Merck & Co expansion plans: (Spicy IP),India : US patent reform and the Indian generics market: (Patent… [read post]
15 Jul 2007, 6:11 pm
Boehringer Ingelheim Pharma GmbH Co. [read post]
26 Apr 2007, 9:28 am
The two big trade mark decisions of the European Court of Justice today have been a little overshadowed by the festivities for World Intellectual Property Day, but the IPKat took just enough time off from his ecstatic celebrations to check the Curia website and see what the ECJ had in store for him.Right: objection to the repackaging of pharma products has led to some grey goods traders taking extreme measures to avoid trade mark infringment litigationCase C-348/04, Boehringer… [read post]
